Conference Reports for NATAP
26th Conference of the Asian Pacific
Association for the Study of the Liver
2017 APASL, Feb 15-19
Clinical Pharmacokinetics and Antiviral Activity of CC-31244, a Pan-genotypic, Potent Nonnucleoside NS5B Polymerase Inhibitor (NNI) for the Treatment of Hepatitis C
Reported by Jules Levin
2017 APASL, Shanghai
Sam Lee, Ph.D.